Silencing of HOXC6 is capable of inhibiting epithelial-mesenchymal transition (EMT) through the inactivation of the transforming growth factor-beta (TGF-β)/Smad signaling pathway in cervical carcinoma cells [14]. The gene discussed is TGFB1; the disease is cervical carcinoma.